News | September 26, 2022
NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
Company leadership is framing the move as transformational.
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Subscribe To Our Newsletter & Stay Updated
